Related references
Note: Only part of the references are listed.A Phase 1, Open-Label, Pharmacokinetic Trial to Investigate Possible Drug-Drug Interactions Between Clobazam, Stiripentol, or Valproate and Cannabidiol in Healthy Subjects
Gilmour Morrison et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2019)
Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
Elizabeth A. Thiele et al.
LANCET (2018)
Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome
Orrin Devinsky et al.
NEUROLOGY (2018)
Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome
Orrin Devinsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
Lesley Taylor et al.
CNS DRUGS (2018)
Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial
Kerri A. Schoedel et al.
EPILEPSY & BEHAVIOR (2018)
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
Orrin Devinsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
A preliminary evaluation of the relationship of cannabinoid blood concentrations with the analgesic response to vaporized cannabis
Barth L. Wilsey et al.
JOURNAL OF PAIN RESEARCH (2016)
Are cannabidiol and Δ9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review
John M. McPartland et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Controlled Cannabis Vaporizer Administration: Blood and Plasma Cannabinoids with and without Alcohol
Rebecca L. Hartman et al.
CLINICAL CHEMISTRY (2015)
Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy
Alexandra L. Geffrey et al.
EPILEPSIA (2015)
Molecular Targets of Cannabidiol in Neurological Disorders
Clementino Ibeas Bih et al.
NEUROTHERAPEUTICS (2015)
A phase I study to assess the effect of food on the single dose bioavailability of the THC/CBD oromucosal spray
C. G. Stott et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Cannabinoid- and lysophosphatidylinositol-sensitive receptor GPR55 boosts neurotransmitter release at central synapses
Sergiy Sylantyev et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Minireview: Recent Developments in the Physiology and Pathology of the Lysophosphatidylinositol-Sensitive Receptor GPR55
Christopher M. Henstridge et al.
MOLECULAR ENDOCRINOLOGY (2011)
Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users
Johannes G. Ramaekers et al.
PSYCHOPHARMACOLOGY (2011)
Ethanol increases plasma Δ9-tetrahydrocannabinol (THC) levels and subjective effects after marihuana smoking in human volunteers
SE Lukas et al.
DRUG AND ALCOHOL DEPENDENCE (2001)
Share Paper
